Literature DB >> 21388316

Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes.

Julie R Ingelfinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388316     DOI: 10.1056/NEJMe1014147

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

Review 2.  Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.

Authors:  Hiroyuki Kobori; Masumi Kamiyama; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Investig Med       Date:  2013-02       Impact factor: 2.895

Review 3.  Improvements in the Management of Diabetic Nephropathy.

Authors:  Evangelia Dounousi; Anila Duni; Konstantinos Leivaditis; Vasilios Vaios; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Rev Diabet Stud       Date:  2015-08-10

4.  Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes.

Authors:  Masumi Kamiyama; Andrea Zsombok; Hiroyuki Kobori
Journal:  J Pharmacol Sci       Date:  2012-07-31       Impact factor: 3.337

5.  Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.

Authors:  Feng Ling Wang; Li Qin Tang; Feng Yang; Ling Na Zhu; Ming Cai; Wei Wei
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

6.  Mortality rates in trials of subjects with type 2 diabetes.

Authors:  Ebrahim Barkoudah; Hicham Skali; Hajime Uno; Scott D Solomon; Marc A Pfeffer
Journal:  J Am Heart Assoc       Date:  2012-02-20       Impact factor: 5.501

7.  Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.

Authors:  Masumi Kamiyama; Michelle K Garner; Kristina M Farragut; Tadashi Sofue; Taiga Hara; Takashi Morikawa; Yoshio Konishi; Masahito Imanishi; Akira Nishiyama; Hiroyuki Kobori
Journal:  Int J Biol Sci       Date:  2014-05-03       Impact factor: 6.580

8.  Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice.

Authors:  Xiu Hong Yang; Yu Pan; Xiao Li Zhan; Bao Long Zhang; Li Li Guo; Hui Min Jin
Journal:  Oxid Med Cell Longev       Date:  2016-09-06       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.